Browser Not Supported

It looks like you're using an outdated browser. To view this site properly, please switch to a more modern browser such as Chrome,Firefox, or Edge.

Meropenem

Date last published:

For the treatment of infection in child cancer as per the National Febrile Neutropenia protocol

This document is only valid for the day on which it is accessed. Please read our .
Child cancer

Infection (National Febrile Neutropenia protocol)

IV 
Child 1 month - 18 years40mg/kg q8h (max dose 2g/dose q8h)  

 

Preparations

500mg, 1g inj. HML restricted (accepted in SSH and CHCH and shared care centres on National Febrile Neutropenia protocol).

Tools